XILLIX ANNOUNCES YEAR END FINANCIAL RESULTS FOR 2005-PROVIDES UPDATE ON ONCO-LIFE'TM' COLON CANCER TRIAL

Xillix Technologies Corp., the world leader in fluorescence endoscopy for the early detection of cancer, today announced results for the year ended December 31, 2005. The Company also provided an update on the upcoming Onco-LIFETM international colon cancer trial.

CCN Matthews (http://www.ccnmatthews.com/news/releases/show.jsp?action=showRelease&searchText=false&showText=all&actionFor=582024)